Interestingly, the down‐regulated expression of ALKBH5 and FTO was found to be related to poor overall survival and cancer‐specific survival in renal cell carcinoma, which implied that ALKBH5 and FTO could serve as potential prognostic biomarkers.43 The gene discussed is ALKBH5; the disease is hereditary clear cell renal cell carcinoma.